KLK3 and prostate carcinoma: The association between 5-ARIs and prostate cancer has been already investigated before, concluding that although 5-ARIs reduce overall prostate cancer risk, it may increase the risk of high-grade disease in men who are undergoing regular screening for prostate cancer using PSA and rectal examination [23].